The Change of Sympathetic Activity During Continuous Positive Airway Pressure Therapy in Obstructive Sleep Apnea Patients with and without Hypertension.

Slides:



Advertisements
Similar presentations
Medical Complications
Advertisements

Obesity Hypoventilation Syndrome
Hypertension and sleep apnea in CKD stage 5 Dr. Christopher Chan Associate Professor of Medicine University of Toronto Toronto General Hospital University.
Sleep Apnea and Cardiovascular Disease
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
OBSTRUCTIVE SLEEP-RELATED BREATHING DISORDERS IN ADULTS DR. MOHSEN PAZOOKI.
Sepsis.
Obstructive Sleep Apnea and Cardiovascular Disease: A Tale of Two Unhappy Bedfellows Najib Ayas MD MPH Associate Professor of Medicine Sleep Disorders.
Phyllis K Stein, Ph.D. Heart Rate Variability Laboratory
Early Identification of Obstructive Sleep Apnea and Prevention of Long Term Health Risks Becky Ellis, RN, BSN.
Central Sleep Apnea in Adults: Causes and Treatment Timothy Daum MD Spectrum Health Grand Rapids.
Sleep and Cardiovascular Disease KD Weeks, MD, FACC, FAASM.
Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure R1 李明峰 / Dr. 劉育志.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
VBWG IDEAL: The Incremental Decrease in End Points Through Aggressive Lipid Lowering Study.
Obstructive Sleep Apnea: Is it in your Differential? Helene Hill Professor Sam Powdrill PAS 645.
September 11, 2012 Mike Hummel Watermark Medical Obstructive Sleep Apnea (OSA) Impacting Workplace Safety and Cost.
Obstructive Sleep Apnea and Heart Disease
Sleep Apnea in the Cardiac Patient Stephen Jennison.
10th Meeting of the Mediterranean Group for the Study of Diabetes Istanbul – April 26-29, 2007 Lung dysfunctions in Metabolic Syndrome and Diabetes Prof.
OSA Pathogenesis, Co-morbidities and Outcomes John Reid, MD FRCP(C) RMGIM Conference, Banff November 24, 2012.
OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE By Ahmad Younis Professor.
Sleep Apnea: …the heart suffers even while sleeping… Adrián Baranchuk Associate Professor of Medicine and Physiology Queen’s University Kingston, Ontario,
Dr. Atapour Nephrologist. Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in.
Sleep Apnea: …the heart suffers even in our sleep... Adrián Baranchuk Associate Professor of Medicine and Physiology Queen’s University Kingston, Ontario,
Pediatric Sleep-Disordered Breathing
Obstructive Sleep Apnea 442 Med Course Prepared by: Prof. Ahmed BaHammam.
Respiratory complications of obesity. Obesity has significant effects upon the pulmonary mechanics. BMI has a direct relationship with the degree of airways.
Depressive Disorders and Cardiovascular Medicine Lawson Wulsin, MD Copyright © World Psychiatric Association.
Evaluating a Case of Sleep Apnoea Dr J.M. Joshi Professor and Head Department of Pulmonary Medicine T.N. Medical College B.Y.L. Nair Hospital Mumbai.
Chronic North American Ginseng Administration Alters Metabolic Variables in the Rat Megan Migchels Supervisor: Dr. J. Ciriello 2011/01/24.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
DR ZIAD NOFAL CARDIOLOGIST DAMASCUS HOSPITAL.  Involvement of peripheral and autonomic nervous systems  Most common complication of diabetes  Underdiagnosed.
Sleep Apnea and Cardiovascular Disease Randy A. Jordan, M.D. Interventional Cardiologist CMO-Jack Stephens Heart Institute CHI St. Vincent Heart Clinic.
Osteopathic Manipulative Treatment and Its Relationship to Autonomic Nervous System Activity as Demonstrated by Heart Rate Variability Charles E. Henley,
Table 1. Articles about the autonomic nervous system comparing normotension and different types of hypertension, organized in chronological order Natália.
NON INVASIVE VENTILATION IN OBESE HYPOVENTILATION SYNDROME:
Chapter Five Sleep Alterations Chapter 5-1 Fourth Edition Linda D. Urden Kathleen M. Stacy Mary E. Lough Priorities in C RITICAL C ARE N URSING Copyright.
Journal Club February 7, 2014 Sadie T. Velásquez, MD.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Obstructive Sleep Apnea Treatment on Atrial.
Obstructive Sleep Apnea 441 Med Course Ahmed BaHammam.
T HREE STRIKES IS ENOUGH Karalyn J Huxhagen B Pharm FPS AACPA Cardiovascular Health Sleep Apnoea Diabetes.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Obstructive Sleep Apnea and Heart Failure: Pathophysiologic.
Date of download: 7/15/2016 Copyright © The American College of Cardiology. All rights reserved. From: Obstructive sleep apnea and cardiovascular disease.
Heart Rate Variability in Men with Erectile dysfunction Ji Yong Lee, Kwan-Joong Joo 1, Jin Tae Kim 2, Sung Tae Cho 3, Dae Sung Cho, Yong-Yeun Won, Jong.
Prof. Dr. ABDUL HAMEED AL QASEER
/ Indexes: linear on frequency domain.
Atrial Fibrillation and Obstructive Sleep Apnea
Optimizing heart failure therapy with implantable sensors
Obstructive Sleep Apnea
Cardiac Output, Venous Return, and Their Regulation
Judith H. Veis, MD, FACP Associate Director, Nephrology
Κολπικη μαρμαρυγη σε ασθενεις με αποφρακτικη υπνικη απνοια
Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.
Obstructive Sleep Apnea and Cardiovascular Disease
What It Is and Why It Matters
Ashish Shukla et al. JACEP 2015;1:41-51
Dileep Raman et al. JACEP 2017;3:
Insights into the pathophysiology of OSA
Diagnostic and management strategy recommended in obstructive sleep apnoea syndrome (OSAS) suspicion [52, 75–77]. Diagnostic and management strategy recommended.
Vicente Arroyo, Carlos Terra, Pere Ginès  Journal of Hepatology 
Insights into the pathophysiology of OSA
Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.
Arterial oxygen saturation (SaO2) patterns during sleep in obstructive sleep apnoea (OSA) alone and the overlap syndrome. Arterial oxygen saturation (SaO2)
Kaplan–Meier survival curves for outcomes among chronic obstructive pulmonary disease (COPD) patients without obstructive sleep apnoea (OSA) (COPD group),
Generalised anxiety symptoms
Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.
Obesity hypoventilation syndrome (OHS) management strategy.
The complexity of obstructive sleep apnoea (OSA) for consideration in a personalised medicine approach. The complexity of obstructive sleep apnoea (OSA)
SA-3000P Result Reading Guide.
Presentation transcript:

The Change of Sympathetic Activity During Continuous Positive Airway Pressure Therapy in Obstructive Sleep Apnea Patients with and without Hypertension 于鍾傑 Chung-Chieh Yu Division of Pulmonary and Critical Care Medicine Chang Gung Memorial Hospital, Keelong

Cardiovascular Consequences of Obstructive Sleep apnea Hypopnea Syndrome (OSAHS) Cardiovascular event: Hypertension Peppard et al. NEJM 2000(WSCS n=709) Nieto et al. JAMA 2000(SHHS n=6,132) Increased mortality and morbidity in coronary artery disease with OSAHS Mooe et al AJRCCM 2001: 164; High prevalence of OSAHS in CHF(2.4X) and stroke(1-2.5X) Shahar et al. AJRCCM 2001

Hypothesis of Cardiovascular Consequences Chronic effect on inflammatory mediator Maillard D 1997 Wessendorf 2000 Reinhart WH 2002 Endothelium dysfunction Lavie et al 2002 Ip et al 2000 Autonomic dysfunction Somers et al J Clin Invest 1995 Narkiewicz et al 1998

Acute cardiovascular effects of OSAHS Normal sleep induces a fall in BP –Reduced heart rate, stroke volume, cardiac output. –Reduced peripheral resistance, sympathetic nervous system activity. OSAHS causes cyclical oscillations in the these variables due to: –Exaggerated negative intra-thoracic pressure. –Hypoxia. –Recurrent arousals.

Example of obstructive apnoea

Recurrent episodes of hypertension Somers et al J Clin Invest 1995

Chronic Effects Increased sympathetic nerve activity Narkiewicz et al 1998

Nieto FJ et al. JAMA 2000;283: Associations of SDB with Hypertension

HRV analysis may represent an accurate and inexpensive screening tool in suspected OSAHS. Frederic R. et al. Circulation. 1999;100: ↑SDNN, VLF,LH, HF at night time. Micheal C. K. Khoo et al. Sleep 1999;22;443-51

CPAP treatment decreases muscle sympathetic traffic in patients with OSA. Narkiewicz K et al. Circulation. 1999;100(23): CPAP treatment decreased HR, noradrenaline plasma level,and BP Heitmann J et al. European Respiratory Journal. 2004;23(2): CPAP treatment is effective in improving autonomic activities by way of eliminating apnea and reversing hypoxemia. Guo Xiheng et al. Chin J Tuber Respir Dis 1998;21(8): 480-3

Autonomic nervous system is involved in the development of hypertension. Emily B. Schroeder et al. Hypertension 2003;42: LF was associated with incident hypertension.(low LF) Jagmeet P. et al. Hypertension 1998;32:293-97

Question 1. Is there sympathetic activity difference between normotensive and hypertensive patients with OSAS ? 2. How the sympathetic activity change during CPAP therapy between two group?

Method Retrospective study Enrolled 84 OSAHS and physician recommend CPAP therapy(consecutive one year) Eliminate 14 patients (CHF, CAD, DM, and stroke, and atrial fibrillation) HRV data ( SDNN, LF, and HF) derive from initial diagnostic PSG and second CPAP titration

Heart Rate Variability(HRV) Non-invasive Well establish Commercial tool

Heart Rate Variability(HRV) SDNN : standard deviation of all R-R intervals LF: Low frequency ( ~ 0.04 to 0.15 Hz) that are sensitive to changes in cardiac sympathetic nerve activity (LF: Both sympathetic and parasympathetic activity) HF: High frequency( ~ 0.15 to 0.4 Hz) that are synchronized to the respiratory rhythm and primarily modulated by cardiac parasympathetic innervation (HF: Parasympathetic activity) LF/HF ratio: generally considered to provide a good index of sympathetic modulation (LF/HF: sympathetic activity)

Summary CPAP reduce heart rate variability(SDNN) for all OSAHS pateints. The HRV has no statistic difference between normotensive and hypertensive subjects before CPAP therapy. OSAHS subjects with hypertension have greater sympathetic activity reduction( △ LF and △ LF/HF ) than normotensive during CPAP therapy.

OSAHS patients with HTN have greater benefit when receive CPAP therapy. OSAS patients with HTN need aggressive management.